BJ-HCC-20, a potential novel cancer-testis antigen

Biochem Cell Biol. 2004 Oct;82(5):577-82. doi: 10.1139/o04-056.

Abstract

In an effort to identify novel Cancer-Testis genes, we analyzed the sequence in the q26-28 region of human X chromosome by several on-line tools. The candidate sequences were then confirmed by experiments. We have obtained a novel Cancer-Testis gene, BJ-HCC-20. In vivo, it was found to have two isoforms. In samples of liver, colon, gastric and lung cancer tested, the expression frequency of BJ-HCC-20 is 25%, 17%, 21% and 15%, respectively. Full-length cDNAs of both BJ-HCC-20 isoforms were isolated and their gene structures and promoter regions were characterized. BJ-HCC-20 might have implications in theoretical and practical tumor biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / genetics*
  • Antigens, Neoplasm / metabolism
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Chromosomes, Human, X / genetics*
  • Humans
  • Male
  • Promoter Regions, Genetic / genetics
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Testicular Neoplasms / genetics*
  • Testicular Neoplasms / metabolism
  • Testis / metabolism*

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Protein Isoforms